WallStreetZenWallStreetZen

NASDAQ: ASBP
Aspire Biopharma Holdings Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Aspire Biopharma Holdings earnings were -$1.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ASBP earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$738.5k, up 203.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ASBP reported annual earnings of -$1.3M, with 264.8% growth.

ASBP earnings history

Current Revenue
$0.0
Current Earnings
-$1.3M
Current Profit Margin
0%

ASBP Return on Equity

Insufficient data to display

ASBP undefined

Current Company
-19.1%
Current Industry
-0.4%
ASBP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ASBP announces earnings.

ASBP undefined

Current Company
78.62%
Current Industry
5.9%
ASBP's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ASBP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ASBP-$1.21M-$1.31MN/A-$0.03
MLEC-$5.72M-$8.28MN/A-$0.21
RADXN/A-$25.69MN/A-$12.13
DARE-$4.01M-$4.05MN/A-$0.48
CLNN-$33.17M-$39.40MN/A-$5.67
View Top Biotech Stocks

Aspire Biopharma Holdings Earnings Reports & History FAQ

What were Aspire Biopharma Holdings's earnings last quarter?

Aspire Biopharma Holdings (NASDAQ: ASBP) reported Q4 2024 earnings per share (EPS) of $0.40, up 290.48% year over year. Total ASBP earnings for the quarter were -$738.50 thousand. In the same quarter last year, Aspire Biopharma Holdings's earnings per share (EPS) was -$0.21.

If you're new to stock investing, here's how to buy Aspire Biopharma Holdings stock.

Is Aspire Biopharma Holdings profitable or losing money?

As of the last Aspire Biopharma Holdings earnings report, Aspire Biopharma Holdings is currently losing money. Aspire Biopharma Holdings's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$1.31 million, a 264.8% increase year over year.

What was ASBP's earnings growth in the past year?

As of Aspire Biopharma Holdings's earnings date in Q2 2025, Aspire Biopharma Holdings's earnings has grown year over year. ASBP earnings in the past year totalled -$1.31 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.